Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | PTGES | O14684 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25752966 | 0.99 | L3MBTL1 (0.37) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL25752931 | 0.96 | KDM4E (0.40) | KDM4EATML3MBTL1PDE10ATET2 | |
| SCHEMBL25752930 | 0.96 | KDM4E (0.40) | KDM4EATML3MBTL1PDE10ATET2 | |
| SCHEMBL25752933 | 0.94 | KDM4E (0.41) | KDM4EATML3MBTL1PDE10ATET2 | |
| SCHEMBL25752949 | 0.93 | TSPO (0.35) | KDM4EL3MBTL1TSPOPTGESNPY5R | |
| SCHEMBL25752948 | 0.93 | TSPO (0.35) | KDM4EL3MBTL1TSPOPTGESNPY5R | |
| SCHEMBL26375940 | 0.92 | KDM4E (0.34) | KDM4EATML3MBTL1 | |
| SCHEMBL26375943 | 0.92 | KDM4E (0.34) | KDM4EATML3MBTL1PTGESMEN1 | |
| SCHEMBL25752952 | 0.92 | TSPO (0.36) | KDM4EL3MBTL1TSPOPTGESNPY5R | |
| SCHEMBL26375992 | 0.91 | KDM4E (0.36) | KDM4EATML3MBTL1PTGESMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217807-A1 | HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230217807-A1 | HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | CRY1, CYP1A1, CYP1B1 | KDM4E 2724/4885ATM 3848/4885L3MBTL1 992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.